Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes.
We evaluated incretin secretion and dipeptidyl peptidase (DPP)-IV activity in Korean type 2 diabetic patients compared with non-diabetic subjects. Type 2 diabetic patients showed intact GLP-1 and total GIP levels similar to those in non-diabetic subjects. Serum DPP-IV activity was significantly higher in type 2 diabetic patients (p=0.022).
Han
Seung Jin
SJ
Department of Endocrinology and Metabolism, Ajou University School of Medicine, San 5, Wonchon-dong, Yeongtong-gu, Suwon, Gyeonggi-do, Republic of Korea.
Kim
Hae Jin
HJ
Choi
Sung-E
SE
Kang
Yup
Y
Lee
Kwan Woo
KW
Kim
Dae Jung
DJ
D044466:Asian People; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000378:metabolism*; D018819:Dipeptidyl Peptidase 4 / Q000097:blood*; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000097:blood; D006801:Humans; D054795:Incretins / Q000378:metabolism*; D008297:Male; D008875:Middle Aged
D054795:Incretins; D052216:Glucagon-Like Peptide 1; D018819:Dipeptidyl Peptidase 4